Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Blocking interferon-gamma might help treat various autoimmune diseases.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Anti-TNF therapy can cause hair loss and skin issues.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Some Korean herb extracts can reduce inflammation and are safe for skin use.

Osmanthus fragrans var. aurantiacus Makino may help treat inflammation due to its antioxidative and anti-inflammatory properties.

Melatonin reduced oxidative damage, inflammation, and protected hair cells in scalded rats.

Ginger peel polysaccharides modified with zinc effectively reduce inflammation.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Psoriasis can cause temporary or permanent hair loss.

A patient lost all their hair while on rheumatoid arthritis medication.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Hair loss is common in IBD patients, and some medications may lower the risk.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Many patients in the rheumatology clinic adjusted or stopped their medications due to side effects.